Although Guo et al. found that the transcription factor RUNX2 upregulates the chemokine receptor CXCR4 to promote the invasive and metastatic potential of human GC [18], research on RUNX2 in GC has been rarely been conducted. The gene discussed is CXCR4; the disease is gastric cancer.